Released Mar 11, 2016, after the close
10-K filed Mar 11, 2016, 71 days after period end · 0001144204-16-087539
Q4 2015 · 10-K
Revenue—
Net Income-$7.75M-$7.75M N/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.45-$0.45 no prior Q4 2014 on fileN/M vs Q3 2015
Operating Incomederived-$8,176,281N/M
Operating Cash Flowderived-$5,455,200N/M
Free Cash Flowderived-$5,465,470N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015 | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012 |
|---|---|---|---|---|
| Net Income | -$7.75M | -$6.23M | -$6.05M | -$3.79M |
| EPS Diluted | -$0.45 | — | — | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR